<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<title>American Century One Choice Blend+ 2060 Portfolio A Class — News on 6ix</title>
<link>https://6ix.com/company/american-century-one-choice-blend-2060-portfolio-a-class</link>
<description>Latest news and press releases for American Century One Choice Blend+ 2060 Portfolio A Class on 6ix.</description>
<language>en-us</language>
<lastBuildDate>Tue, 21 Apr 2026 04:00:00 GMT</lastBuildDate>
<generator>6ix RSS</generator>
<atom:link href="https://6ix.com/rss/company/american-century-one-choice-blend-2060-portfolio-a-class" rel="self" type="application/rss+xml" />
<item>
<title>Wave Life Sciences Announces Hearing on Proposed Redomiciliation to the United States</title>
<link>https://6ix.com/company/american-century-one-choice-blend-2060-portfolio-a-class/news/wave-life-sciences-announces-hearing-on-proposed-redomiciliation-to-the-united-states-11</link>
<guid isPermaLink="true">https://6ix.com/company/american-century-one-choice-blend-2060-portfolio-a-class/news/wave-life-sciences-announces-hearing-on-proposed-redomiciliation-to-the-united-states-11</guid>
<pubDate>Tue, 21 Apr 2026 04:00:00 GMT</pubDate>
<description>CAMBRIDGE, Mass., April 21, 2026 (GLOBE NEWSWIRE) -- As previously announced, Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage biotechnology company</description>
</item>
<item>
<title>Princeton Bancorp, Inc. Announces Declaration of a $0.35 Quarterly Cash Dividend</title>
<link>https://6ix.com/company/american-century-one-choice-blend-2060-portfolio-a-class/news/princeton-bancorp-inc-announces-declaration-of-a-dollar035-quarterly-cash-dividend-7</link>
<guid isPermaLink="true">https://6ix.com/company/american-century-one-choice-blend-2060-portfolio-a-class/news/princeton-bancorp-inc-announces-declaration-of-a-dollar035-quarterly-cash-dividend-7</guid>
<pubDate>Tue, 21 Apr 2026 04:00:00 GMT</pubDate>
<description>PRINCETON, N.J.--(BUSINESS WIRE)-- Princeton Bancorp, Inc. (the “Company”) (NASDAQ - BPRN), the bank holding company for The Bank of Princeton (the “Bank”),</description>
</item>
<item>
<title>Disc Medicine Announces Oral Presentation of Data from RALLY-MF Phase 2 Trial of DISC-0974 in Patients with Myelofibrosis and Anemia at the American Society of Clinical Oncology (ASCO) Annual Meeting</title>
<link>https://6ix.com/company/american-century-one-choice-blend-2060-portfolio-a-class/news/disc-medicine-announces-oral-presentation-of-data-from-rally-mf-phase-2-trial-of-disc-0974-in-patients-with-myelofibrosis-and-anemia-at-the-american-society-of-clinical-oncology-asco-annual-meeting-8</link>
<guid isPermaLink="true">https://6ix.com/company/american-century-one-choice-blend-2060-portfolio-a-class/news/disc-medicine-announces-oral-presentation-of-data-from-rally-mf-phase-2-trial-of-disc-0974-in-patients-with-myelofibrosis-and-anemia-at-the-american-society-of-clinical-oncology-asco-annual-meeting-8</guid>
<pubDate>Tue, 21 Apr 2026 04:00:00 GMT</pubDate>
<description>WATERTOWN, Mass., April 21, 2026 (GLOBE NEWSWIRE) -- Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery,</description>
</item>
<item>
<title>Enpro Announces Date for First Quarter 2026 Earnings Release and Conference Call</title>
<link>https://6ix.com/company/american-century-one-choice-blend-2060-portfolio-a-class/news/enpro-announces-date-for-first-quarter-2026-earnings-release-and-conference-call-23</link>
<guid isPermaLink="true">https://6ix.com/company/american-century-one-choice-blend-2060-portfolio-a-class/news/enpro-announces-date-for-first-quarter-2026-earnings-release-and-conference-call-23</guid>
<pubDate>Tue, 21 Apr 2026 04:00:00 GMT</pubDate>
<description>CHARLOTTE, N.C.--(BUSINESS WIRE)-- Enpro Inc. (NYSE: NPO) will release financial results for the first quarter of 2026 on Tuesday, May 5, at 6:30 a.m.</description>
</item>
</channel>
</rss>